MICRORNA (MIRNA)

Global Market Trajectory & Analytics

MCP13362

VALIDATED EXECUTIVE ENGAGEMENTS

OUTREACH

2994
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

539
Interactions with Platform & by Email

PARTICIPANTS

92
Unique # Participated

VALIDATIONS

41
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JUL 2020

TABLES

156

PAGES

228

EDITION

9

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for microRNA (miRNA) estimated at US$225.5 Million in the year 2020, is projected to reach a revised size of US$556.1 Million by 2027, growing at a CAGR of 13.8% over the period 2020-2027.Products, one of the segments analyzed in the report, is projected to grow at a 12.2% CAGR to reach US$290.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 15.7% CAGR for the next 7-year period. This segment currently accounts for a 42.6% share of the global microRNA (miRNA) market.
The microRNA (miRNA) market in the U.S. is estimated at US$97 Million in the year 2020. The country currently accounts for a 43.01% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$60 Million in the year 2027 trailing a CAGR of 17.7% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR while Rest of European market (as defined in the study) will reach US$60 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abcam PLC; Agilent Technologies, Inc.; Bioline GmbH; Bio-Rad Laboratories, Inc.; BioVendor - Laboratorni medicina a.s; Dharmacon, Inc.; F. Hoffmann-La Roche AG; GeneCopoeia, Inc.; HTG Molecular Diagnostics, Inc.; Illumina, Inc.; Kaneka Eurogentec SA; MilliporeSigma; Miltenyi Biotec GmbH; Nanostring Technologies, Inc.; New England Biolabs, Inc.; Promega Corporation; Qiagen NV; Rosetta Genomics Ltd.; System Biosciences, Inc.; Thermo Fisher Scientific, Inc.
» Type (Products, Services) » Application (Cancer, Infectious Diseases, Immunological Disorders, Cardiovascular Diseases, Neurological Diseases, Other Applications) » End-Use (Academic & Government Research Institutes, Biotech & Pharma Companies, Other End-Uses)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
microRNA (miRNA) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Global Competitor Market Shares by Segment
Products (Type) Global Competitor Market Share Positioning for 2019 & 2025
Services (Type) Market Share Breakdown of Key Players: 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
microRNA (miRNA) Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
microRNA (miRNA) Global Retrospective Market Scenario in US$ by Region/Country: 2012-2019
microRNA (miRNA) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
World Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Immunological Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Immunological Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunological Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Neurological Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Neurological Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Neurological Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biotechnology & Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Biotechnology & Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotechnology & Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic & Government Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
Market Facts & Figures
US miRNA Market Share (in %) by Company: 2019 & 2025
Products (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
Services (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025
USA Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
USA Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
USA Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
China Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
China Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
European miRNA Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Products (Type) Market Share (in %) by Company in Europe: 2019 & 2025
Services (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025
European microRNA (miRNA) Market Demand Scenario in US$ by Region/Country: 2020-2027
microRNA (miRNA) Market in Europe: A Historic Market Perspective in US$ by Region/Country for the Period 2012-2019
European microRNA (miRNA) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
Europe Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
France Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
France Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
UK Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
UK Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for miRNA by Type - Products and Services - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for miRNA by Type - Products and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for miRNA by Type - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for miRNA by Application - Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for miRNA by Application - Percentage Breakdown of Value Sales for Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Other Applications for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for miRNA by End-Use - Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for miRNA by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled : 42

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com